MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nolan, R. D.
Right arrow Articles by Eling, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nolan, R. D.
Right arrow Articles by Eling, T. E.

Role of arachidonic acid metabolism in the mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor

RD Nolan, RM Danilowicz and TE Eling

Laboratory of Molecular Biophysics, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709.

We have investigated the involvement of arachidonic acid release and metabolism in the mitogenic response, i.e., [3H]thymidine incorporation, to epidermal growth factor (EGF) in BALB/c 3T3 cells. EGF induces release of arachidonate and prostaglandin (PG) formation after its addition to BALB/c 3T3 cells at the same concentrations that stimulate mitogenesis. Further, EGF-stimulated mitogenesis is blocked by inhibitors of arachidonate metabolism including indomethacin, eicosatetraynoic acid, and dexamethasone, whereas the addition of major arachidonate products in BALB/c 3T3 cells, PGE2, PGF2 alpha, and their intermediates PGG2 and PGH2, stimulate mitogenesis in synergism with EGF. The addition of PGs to BALB/c 3T3 cells also overcame indomethacin- and eicosatetraynoic acid-inhibited responses to EGF. Indomethacin must be added with EGF in order to block arachidonate metabolism and subsequent mitogenesis. These results suggest that the release of arachidonic acid and its subsequent metabolism is an apparent early requirement for the initiation of cell cycle traversal by EGF.

Volume 33, Issue 6, pp. 650-656, 06/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurosci.Home page
V. Prevot, A. Cornea, A. Mungenast, G. Smiley, and S. R. Ojeda
Activation of erbB-1 Signaling in Tanycytes of the Median Eminence Stimulates Transforming Growth Factor {beta}1 Release via Prostaglandin E2 Production and Induces Cell Plasticity
J. Neurosci., November 19, 2003; 23(33): 10622 - 10632.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Asano, J. Shoda, T. Ueda, T. Kawamoto, T. Todoroki, M. Shimonishi, T. Tanabe, Y. Sugimoto, A. Ichikawa, M. Mutoh, et al.
Expressions of Cyclooxygenase-2 and Prostaglandin E-Receptors in Carcinoma of the Gallbladder: Crucial Role of Arachidonate Metabolism in Tumor Growth and Progression
Clin. Cancer Res., April 1, 2002; 8(4): 1157 - 1167.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Kashiwagi, H Friess, W Uhl, P Berberat, M Abou-Shady, M Martignoni, S E Anghelacopoulos, A Zimmermann, and M W Buchler
Group II and IV phospholipase A2 are produced in human pancreatic cancer cells and influence prognosis
Gut, October 1, 1999; 45(4): 605 - 612.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
E. M. Hill, T. Eling, and P. Nettesheim
Changes in Expression of 15-Lipoxygenase and Prostaglandin-H Synthase during Differentiation of Human Tracheobronchial Epithelial Cells
Am. J. Respir. Cell Mol. Biol., May 1, 1998; 18(5): 662 - 669.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
W. C. Glasgow, R. Hui, A. L. Everhart, S. P. Jayawickreme, J. Angerman-Stewart, B.-B. Han, and T. E. Eling
The Linoleic Acid Metabolite, (13S)-Hydroperoxyoctadecadienoic Acid, Augments the Epidermal Growth Factor Receptor Signaling Pathway by Attenuation of Receptor Dephosphorylation. DIFFERENTIAL RESPONSE IN SYRIAN HAMSTER EMBRYO TUMOR SUPPRESSOR PHENOTYPES
J. Biol. Chem., August 1, 1997; 272(31): 19269 - 19276.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Rage, D. F. Hill, M. Sena-Esteves, X. O. Breakefield, R. J. Coffey, M. E. Costa, S. M. McCann, and S. R. Ojeda
Targeting transforming growth factor alpha  expression to discrete loci of the neuroendocrine brain induces female sexual precocity
PNAS, March 18, 1997; 94(6): 2735 - 2740.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G Bunt, J de Wit, H van den Bosch, A. Verkleij, and J Boonstra
Ultrastructural localization of cPLA2 in unstimulated and EGF/A23187-stimulated fibroblasts
J. Cell Sci., January 10, 1997; 110(19): 2449 - 2459.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics